Clinical trial
Study of TCR Alpha Beta T-Cell and CD19 B-Cell Depletion for Hematopoietic Cell Transplantation From Haploidentical Donors in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
NCT04414046 is registered in ClinicalTrials.gov with Johns Hopkins All Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of TCR Alpha Beta T-Cell and CD19 B-Cell Depletion for Hematopoietic Cell Transplantation From Haploidentical Donors in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
- Lead sponsor
- Johns Hopkins All Children's Hospital
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- July 22, 2020
- Completion date
- June 30, 2027
- Enrollment
- 17 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metabolic disease, primary immune deficiency disorders